J.P. Morgan Thinks Phreesia’s Stock is Going to Recover

J.P. Morgan analyst Anne Samuel maintained a Buy rating on Phreesia (PHRResearch Report) today and set a price target of $26.00. The company’s shares closed last Thursday at $19.00, close to its 52-week low of $13.19.

According to, Samuel is a 4-star analyst with an average return of 17.9% and a 41.5% success rate. Samuel covers the Technology sector, focusing on stocks such as Convey Holding Parent, Health Catalyst, and Signify Health.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Phreesia with a $34.50 average price target, which is a 91.3% upside from current levels. In a report released today, JMP Securities also maintained a Buy rating on the stock with a $34.00 price target.

See the top stocks recommended by analysts >>

Based on Phreesia’s latest earnings release for the quarter ending January 31, the company reported a quarterly revenue of $58.02 million and GAAP net loss of $46.45 million. In comparison, last year the company earned revenue of $41.81 million and had a GAAP net loss of $8.1 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.

Read More on PHR:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More